Skip to main content

Table 5 Treatment comparisons for TNSS from the diary cards: Period means over five days.

From: Effects of a dual CCR3 and H1-antagonist on symptoms and eosinophilic inflammation in allergic rhinitis

Variable Treatment Mean differencea 95% CI P-value
TNSS
-morning
AZD3778 vs. placebo -0.459 -0.85, -0.067 0.023
  Loratadine vs. placebo -0.174 -0.569, 0.22 0.381
  AZD3778 vs. loratadine -0.285 -0.685, 0.115 0.159
TNSS
-evening
AZD3778 vs. placebo -0.562 -1.04, -0.083 0.022
  Loratadine vs. placebo -0.172 -0.649, 0.305 0.474
  AZD3778 vs. loratadine -0.39 -0.868, 0.088 0.108
  1. AZD3778 reduced TNSS in the morning as well as in the evening.
  2. aAdjusted mean difference from ANOVA.